Short answer
SELECT MEDICAL HOLDINGS CORP (SEM) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $1.4B (up 5.0% year over year) with net income of $44M.
Q1 2026 key financials · XBRL
- Revenue
- $1.4B
- +5.0% YoY
- Net income
- $44M
- −22.4% YoY
- Operating margin
- 6.9%
- EPS (diluted)
- $0.35
- −20.5% YoY
Source: XBRL data from the SELECT MEDICAL HOLDINGS CORP (SEM) Q1 2026 10-Q on SEC EDGAR. USD.
SELECT MEDICAL HOLDINGS CORP Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,421.5M, up 5.0% YoY from $1,353.2M
- Adjusted EBITDA $141.6M, down 6.5% YoY; margin 10.0% vs 11.2%
- Rehabilitation hospitals best performer: revenue $351.9M, up 14.5%; Adjusted EBITDA $81.1M, up 15.1%
- Critical illness recovery hospitals weakest EBITDA trend: Adjusted EBITDA $73.4M, down 15.3%; margin 11.5% vs 13.6%
- Merger expected mid-2026; Medicaid reimbursement headwinds from OBBBA remain unquantified
Risk Factors
- Newly added merger risk triggered by March 2, 2026 agreement: stockholder litigation could delay or prevent closing
- Most material update: merger-related business disruption, including employee retention challenges and diverted management resources
- Regulatory risk: Hart-Scott-Rodino clearance and healthcare change-of-control approvals required before closing
- Operational risk: merger restrictions may block strategic opportunities and share repurchases without Parent consent
- Financial risk: termination could require payment of the Company Termination Fee and leave transaction costs unrecovered
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.